Psychedelic Business Spotlight — January 7
This week in psychedelic business news: Mindset Pharma partners with global pharmaceutical company; Awakn Life Sciences explores behavioral addictions; Ei.Ventures buys virtual land for psychedelic therapy.
field trip health
Ketamine Rapidly Reduces Depression, According to ‘Most Comprehensive Review’ of Evidence — But Patient Experiences Suggest More Applications
Psychedelic Spotlight speaks to a Field Trip Health patient and a psychotherapist, whose experiences suggest ketamine can also treat anxiety among other mental health issues.
Psychedelic Business Spotlight: October 22
This week in psychedelic business news: UK fast tracks DMT for major depressive disorder; Field Trip Health expands its clinical presence in the US; and another psychedelic pharmaceuticals company prepares for the Nasdaq.
World’s Richest Person Elon Musk: ‘People Should Be Open to Psychedelics’
The Tesla and SpaceX founder, estimated to be worth nearly $200 billion, has previously hinted at using DMT.
Psychedelic Business Spotlight: September 10, 2021
This week in psychedelic business news: major DMT development for stroke treatment; a propriety psilocybin formulation has potential to treat obesity; two more companies join the OTC Pink Market.
Field Trip Health Expands Access to Ketamine-Assisted Psychotherapy
Although based in Canada, the company is building a clinical network of therapists trained in ketamine-assisted psychotherapy across the United States.
End of content
End of content